Quanterix Seeks Governance Overhaul, Board Declassification

Ticker: QTRX · Form: DEF 14A · Filed: Aug 25, 2025 · CIK: 1503274

Quanterix Corp DEF 14A Filing Summary
FieldDetail
CompanyQuanterix Corp (QTRX)
Form TypeDEF 14A
Filed DateAug 25, 2025
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.001
Sentimentbullish

Sentiment: bullish

Topics: Corporate Governance, Proxy Statement, Board Declassification, Shareholder Rights, Executive Compensation, Audit Firm Ratification, Supermajority Vote, Biotechnology, Diagnostics

Related Tickers: QTRX

TL;DR

**QTRX is finally giving power back to shareholders by ditching supermajority votes and declassifying the board – bullish for long-term governance!**

AI Summary

Quanterix Corporation (QTRX) is holding its 2025 Annual Meeting on September 23, 2025, to address several key governance changes and routine matters. Stockholders will vote on the election of three director nominees for three-year terms expiring in 2028: Myla Lai-Goldman, Masoud Toloue, and David Walt. The company is also seeking advisory approval for executive compensation and the ratification of KPMG LLP as its independent registered public accounting firm for fiscal year 2025. Crucially, Quanterix proposes three amendments to its Charter to enhance corporate governance: declassifying its Board of Directors, eliminating supermajority stockholder vote requirements for amending certain Charter provisions, and eliminating supermajority stockholder vote requirements for stockholders to amend its Bylaws. These proposed amendments aim to increase stockholder influence and streamline governance, aligning with modern best practices. The Board of Directors unanimously recommends a 'FOR' vote on all proposals.

Why It Matters

This DEF 14A filing signals a significant shift in Quanterix's corporate governance, moving towards greater stockholder empowerment by proposing Board declassification and eliminating supermajority voting requirements. For investors, this means increased influence over the company's strategic direction and executive accountability, potentially boosting investor confidence and stock valuation. Employees and customers could benefit from a more agile and responsive leadership structure, fostering innovation and market competitiveness against rivals in the diagnostics and life sciences sector. The broader market will observe Quanterix's commitment to modern governance, potentially influencing other companies to adopt similar practices.

Risk Assessment

Risk Level: low — The risk level is low because the proposals outlined in the DEF 14A filing, such as Board declassification and eliminating supermajority voting requirements, are generally considered best practices in corporate governance. These changes are designed to increase stockholder influence and accountability, which typically reduces governance-related risks rather than increasing them. The Board of Directors unanimously recommends 'FOR' all proposals, indicating internal alignment.

Analyst Insight

Investors should vote 'FOR' all proposals, particularly the Charter amendments, to support enhanced corporate governance and increased stockholder influence at Quanterix. This move could improve long-term shareholder value by making the company more responsive and accountable. Engage with proxy solicitor Sodali if you have voting questions.

Key Numbers

  • September 23, 2025 — Annual Meeting Date (Date stockholders will vote on proposals)
  • 9:00 a.m. ET — Annual Meeting Time (Start time for the virtual meeting)
  • July 31, 2025 — Record Date (Date for determining voting eligibility)
  • 46,465,915 — Shares Outstanding (Number of common shares entitled to vote as of Record Date)
  • 3 — Director Nominees (Number of directors to be elected for three-year terms)
  • 2028 — Director Term Expiration (Year new directors' terms will expire)
  • 6 — Proposals (Total number of matters to be voted on by stockholders)
  • 47% — Investor Engagement (Percentage of outstanding shares represented by top 20 investors met in 2024)
  • 12 — Top Investors Engaged (Number of top 20 investors met in 2024)
  • 2024 — Annual Report Year (Year of the financial statements included in the Annual Report)

Key Players & Entities

  • Quanterix Corporation (company) — Registrant and Company
  • Masoud Toloue, Ph.D. (person) — President and Chief Executive Officer, Board Nominee
  • Laurie A. Churchill (person) — General Counsel and Secretary
  • KPMG LLP (company) — Independent Registered Public Accounting Firm
  • Myla Lai-Goldman, M.D. (person) — Board Nominee
  • David R. Walt, Ph.D. (person) — Board Nominee
  • Sodali (company) — Proxy Solicitor
  • Securities and Exchange Commission (regulator) — Regulatory body
  • Computershare Trust Company, N.A. (company) — Transfer Agent
  • July 31, 2025 (date) — Record Date for voting eligibility

FAQ

What are the key proposals Quanterix stockholders will vote on at the 2025 Annual Meeting?

Quanterix stockholders will vote on six key proposals at the 2025 Annual Meeting on September 23, 2025. These include electing three director nominees, approving executive compensation on an advisory basis, ratifying KPMG LLP as the independent auditor, and three amendments to the Charter to declassify the Board and eliminate supermajority stockholder vote requirements for Charter and Bylaw amendments.

Who are the director nominees for Quanterix's Board of Directors in 2025?

The Quanterix Board of Directors has nominated three individuals for election to serve three-year terms expiring at the annual meeting of stockholders in 2028. The nominees are Myla Lai-Goldman, M.D., Masoud Toloue, Ph.D., and David R. Walt, Ph.D.

What is the significance of Quanterix proposing to declassify its Board of Directors?

Declassifying the Board of Directors at Quanterix means that all directors would be elected annually, rather than in staggered classes. This change, if approved, increases accountability to stockholders by allowing them to vote on the entire board more frequently, aligning with modern corporate governance best practices.

How will eliminating supermajority vote requirements impact Quanterix stockholders?

Eliminating supermajority stockholder vote requirements for amending certain Charter provisions and the Bylaws will empower Quanterix stockholders by allowing significant corporate changes to be approved with a simple majority vote. This reduces the hurdle for stockholders to influence governance and strategic decisions, making the company more responsive to investor sentiment.

When and where will the Quanterix 2025 Annual Meeting of Stockholders be held?

The Quanterix 2025 Annual Meeting of Stockholders will be held virtually via the Internet at 9:00 a.m. ET, on September 23, 2025. Stockholders must pre-register at www.cesonlineservices.com/qtrxam_vm by 9:00 a.m. ET, on September 22, 2025, to participate.

What is Quanterix's stance on executive compensation for 2025?

Quanterix's Board of Directors recommends that stockholders approve, on an advisory basis, the compensation of the Company's named executive officers. This 'say-on-pay' vote allows stockholders to express their opinion on the executive compensation philosophy and practices.

Who is Quanterix's independent registered public accounting firm for fiscal year 2025?

KPMG LLP has been appointed as Quanterix's independent registered public accounting firm for the fiscal year ending December 31, 2025. Stockholders will be asked to ratify this appointment on an advisory basis at the Annual Meeting.

What is the record date for voting at the Quanterix 2025 Annual Meeting?

The record date for determining which stockholders are entitled to notice of, and to vote at, the Quanterix 2025 Annual Meeting is the close of business on July 31, 2025. As of this date, 46,465,915 shares of common stock were outstanding and entitled to vote.

How can Quanterix stockholders communicate with the Board of Directors?

Quanterix stockholders can communicate with the Board, non-management members, or specific Board members by sending a written communication addressed to the Corporate Secretary by mail to Quanterix Corporation, 900 Middlesex Turnpike Building 1, Billerica, Massachusetts 01821. All relevant communications are reviewed and provided to the Board.

What was Quanterix's stockholder engagement like in 2024?

In 2024, Quanterix demonstrated a commitment to stockholder engagement by having members of its Board and management team meet with approximately 12 of its 20 largest investors. These investors collectively represented approximately 47% of the outstanding shares of Common Stock as of December 31, 2024.

Industry Context

Quanterix operates in the life sciences tools and diagnostics sector, focusing on ultra-sensitive protein detection. The industry is characterized by rapid technological advancements and a growing demand for personalized medicine and advanced research capabilities. Key trends include the development of novel diagnostic assays and the increasing adoption of single-molecule detection technologies for biomarker discovery and clinical applications.

Regulatory Implications

As a publicly traded company, Quanterix is subject to SEC regulations and stock exchange rules. Changes to corporate governance, such as declassifying the board or altering voting thresholds, require careful adherence to proxy solicitation rules and shareholder voting procedures. The company's proposals aim to align with evolving corporate governance best practices, which can influence investor perception and regulatory scrutiny.

What Investors Should Do

  1. Vote on Director Nominees: Stockholders should review the qualifications of the three director nominees (Myla Lai-Goldman, Masoud Toloue, and David Walt) and vote for their election to the Board.
  2. Approve Executive Compensation: Stockholders are asked to provide advisory approval for the company's executive compensation plan. Review the compensation details and vote accordingly.
  3. Ratify Independent Auditors: Vote to ratify the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2025.
  4. Support Charter Amendments: Stockholders are strongly encouraged to vote 'FOR' the three proposed amendments to the Charter and Bylaws, which aim to enhance corporate governance and increase stockholder influence.

Key Dates

  • 2025-09-23: 2025 Annual Meeting of Stockholders — Stockholders will vote on director elections, executive compensation, ratification of auditors, and proposed amendments to the Charter and Bylaws.
  • 2025-07-31: Record Date — Determines which stockholders are eligible to vote at the Annual Meeting.

Glossary

Charter
The company's amended and restated certificate of incorporation, which outlines its fundamental corporate structure and governance. (Proposed amendments to the Charter are a key focus of the Annual Meeting, aiming to declassify the board and remove supermajority vote requirements.)
Bylaws
The rules governing the internal operations and management of the company. (A proposed amendment to the Bylaws seeks to eliminate supermajority stockholder vote requirements for amendments, increasing stockholder influence.)
Supermajority Stockholder Vote Requirement
A voting threshold that requires a higher percentage of votes (e.g., 66.7% or 75%) than a simple majority (50% + 1 vote) to approve a proposal. (The company is proposing to eliminate these requirements for amending certain Charter provisions and Bylaws to streamline governance and empower stockholders.)
Declassify Board of Directors
To move from a classified (staggered) board structure, where directors are elected for overlapping multi-year terms, to an unclassified structure where all directors are elected annually. (A proposed Charter amendment aims to declassify the board, allowing stockholders to vote on all directors annually, potentially increasing accountability.)

Filing Stats: 4,711 words · 19 min read · ~16 pages · Grade level 11.4 · Accepted 2025-08-25 17:23:10

Key Financial Figures

  • $0.001 — holders of our common stock, par value $0.001 per share (our "Common Stock"), will be

Filing Documents

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 54 Proposal No. 3: Ratification of the Appointment of Independent Registered Public Accounting Firm 56 Report of Audit Committee 57 Delinquent Section 16(a) Reports 58 Certain Relationships and Related Person Transactions 59 Proposal No. 4: Approval of an Amendment to our Charter to Declassify our Board 61 Proposal No. 5: Approval of an Amendment to our Charter to Eliminate the Supermajority Stockholder Vote Requirement to Amend Certain Provisions of our Charter 62 Proposal No. 6: Approval of an Amendment to our Charter to Eliminate the Supermajority Stockholder Vote Requirement for Stockholders to Amend our Bylaws 62 Partial Stockholder Approval of Charter Amendment Proposals 64 Additional Information Regarding our Independent Registered Public Accounting Firm 65 Corporate Code of Conduct and Ethics 68 Additional Information 69 Other Matters 69 Stockholder Proposals and Nominations for Director 70 TABLE OF CONTENTS PROXY SUMMARY This proxy statement (this "Proxy Statement"), along with the accompanying notice of the 2025 annual meeting of stockholders (the "Notice"), contains information about the 2025 annual meeting of stockholders of Quanterix Corporation (including any adjournments or postponements of such meeting, the "Annual Meeting") to be held virtually via the Internet at 9:00 a.m. ET, on September 23, 2025, at www.cesonlineservices.com/qtrxam_vm. The Annual Meeting will be held in a virtual meeting format only. If the Annual Meeting is adjourned for any reason, then proxies submitted may be used at any adjournment of the Annual Meeting. In this Proxy Statement, we refer to Quanterix Corporation as "Quanterix," "the Company," "we" and "us." We refer to our amended and restated certificate of incorporation as our "Charter" and our restated bylaws as our "Bylaws." Information About the Annual Meeting You have received these proxy m

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.